Quince Therapeutics (QNCX) Tax Provisions (2022 - 2026)

Quince Therapeutics has reported Tax Provisions for 5 years, with the latest figure at $100000.0 in Q2 2026.

• On a quarterly basis, Tax Provisions rose 49.25% year-over-year to $100000.0 in Q2 2026; TTM through Jun 2026 was -$22.3 million, a 12565.92% decrease from a year earlier, with the FY2025 full-year figure at -$17.0 million, down 12949.24% from the prior year.
• Tax Provisions was $100000.0 for Q2 2026 at Quince Therapeutics, up from -$5.3 million in the prior quarter.
• The five-year high for Tax Provisions was $100000.0 in Q2 2026, with the low at -$17.0 million in Q4 2025.
• Average Tax Provisions over 5 years is -$1.7 million, with a median of $31000.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Tax Provisions jumped 112.5% in 2024, then slumped 32848.08% in 2025.
• Over 5 years, Tax Provisions stood at -$284000.0 in 2022, then soared by 117.96% to $51000.0 in 2023, then climbed by 1.96% to $52000.0 in 2024, then plunged by 32848.08% to -$17.0 million in 2025, then jumped by 100.59% to $100000.0 in 2026.
• The last three Tax Provisions figures came in at $100000.0 (Q2 2026), -$5.3 million (Q1 2026), and -$17.0 million (Q4 2025), per Business Quant data.